Category: AstraZeneca’s Mystic cancer drug trial fails

AstraZeneca’s Mystic cancer drug trial fails

  1. AstraZeneca’s Mystic cancer drug trial fails  MarketWatch
  2. AstraZeneca Posts Q2 Profit; Backs 2017 Outlook  Nasdaq
  3. AstraZeneca shares tumble 15% on big drug trial setback  Financial Times
  4. Full coverage

from Business – Google News http://www.marketwatch.com/story/astrazenecas-mystic-cancer-drug-trial-fails-2017-07-27

Advertisements